BioCorRx Inc. (BICX) Financials Nov 4, 2014, 4:13
Post# of 250675
Posted On: 11/17/2014 4:52:45 AM
BioCorRx Inc. (BICX) Financials Nov 4, 2014, 4:13 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for BioCorRx Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 144,400 771,762 868,161 714,962
Cost of Goods Sold (COGS) incl. D&A 0 177,972 402,605 404,470 295,702
COGS excluding D&A 0 156,219 400,414 402,482 160,187
Depreciation & Amortization Expense 0 21,753 2,191 1,988 135,515
Depreciation 0 21,753 2,191 1,988 3,162
Amortization of Intangibles 0 0 0 0 132,353
Gross Income 0 (33,572) 369,157 463,691 419,260
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 13,197 119,948 712,684 1M 2.92M
Research & Development 0 0 0 0 -
Other SG&A 13,197 119,948 712,684 1M 2.92M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 82,915 1.03M
EBIT after Unusual Expense 0 0 0 (82,915) (1.03M)
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 0 1,070 65,440 260,246 310,403
Gross Interest Expense 0 1,070 65,440 260,246 310,403
Interest Capitalized 0 0 0 0 0
Pretax Income (13,197) (154,590) (408,967) (884,207) (3.84M)
Income Tax 0 0 0 1,600 1,600
Income Tax - Current Domestic 0 0 0 1,600 1,600
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 (365,713) (1.19M)
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 (365,713) (1.19M)
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (13,197) (154,590) (408,967) (885,807) (3.84M)
Minority Interest Expense 0 0 0 0 0
Net Income (13,197) (154,590) (408,967) (885,807) (3.84M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (13,197) (154,590) (408,967) (885,807) (3.84M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (13,197) (154,590) (408,967) (885,807) (3.84M)
EPS (Basic) 0.00 0.00 (0.01) (0.01) (0.03)
Basic Shares Outstanding 429.37M 37M 50.56M 106.15M 117.38M
EPS (Diluted) 0.00 0.00 (0.01) (0.01) (0.03)
Diluted Shares Outstanding 429.37M 37M 50.56M 106.15M 117.38M
EBITDA (13,197) (131,767) (341,336) (539,058) (2.36M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for BioCorRx Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 144,400 771,762 868,161 714,962
Cost of Goods Sold (COGS) incl. D&A 0 177,972 402,605 404,470 295,702
COGS excluding D&A 0 156,219 400,414 402,482 160,187
Depreciation & Amortization Expense 0 21,753 2,191 1,988 135,515
Depreciation 0 21,753 2,191 1,988 3,162
Amortization of Intangibles 0 0 0 0 132,353
Gross Income 0 (33,572) 369,157 463,691 419,260
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 13,197 119,948 712,684 1M 2.92M
Research & Development 0 0 0 0 -
Other SG&A 13,197 119,948 712,684 1M 2.92M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 82,915 1.03M
EBIT after Unusual Expense 0 0 0 (82,915) (1.03M)
Non Operating Income/Expense 0 0 0 0 0
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 - 0
Interest Expense 0 1,070 65,440 260,246 310,403
Gross Interest Expense 0 1,070 65,440 260,246 310,403
Interest Capitalized 0 0 0 0 0
Pretax Income (13,197) (154,590) (408,967) (884,207) (3.84M)
Income Tax 0 0 0 1,600 1,600
Income Tax - Current Domestic 0 0 0 1,600 1,600
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 (365,713) (1.19M)
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 (365,713) (1.19M)
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (13,197) (154,590) (408,967) (885,807) (3.84M)
Minority Interest Expense 0 0 0 0 0
Net Income (13,197) (154,590) (408,967) (885,807) (3.84M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (13,197) (154,590) (408,967) (885,807) (3.84M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (13,197) (154,590) (408,967) (885,807) (3.84M)
EPS (Basic) 0.00 0.00 (0.01) (0.01) (0.03)
Basic Shares Outstanding 429.37M 37M 50.56M 106.15M 117.38M
EPS (Diluted) 0.00 0.00 (0.01) (0.01) (0.03)
Diluted Shares Outstanding 429.37M 37M 50.56M 106.15M 117.38M
EBITDA (13,197) (131,767) (341,336) (539,058) (2.36M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)